Presentation on theme: "Lessons Learned from the Reverse Distribution Industry and Implications for National Consumer Take-Back Programs 5th Annual Maine Benzodiazepine Study."— Presentation transcript:
Industry Overview What is a Reverse Distributor? –Returning Potentially Creditable Pharmaceuticals –Waste Determination and Management at Reverse Distributor’s Facility –Assisting Current Customers in Waste Management and Education by: Initial training of Pharmacy staff by Reverse Distributor personnel Processing report data that includes reasons for credit ineligibility Non-compliance incident reports
Regulatory Challenges –DEA: Memorandum of Understanding Allow Bay Area pilot program –USPS: Packaging & Labeling Acceptable Materials –State: MWMA (Medical Waste Management Act) LTC Homes SB966 (signed by Governor Schwarzenegger)
Differing Opinions –Materials Collected: Non-Controlled Substances Controlled Substances Medical Waste –Type Of Program: Drop-Off vs. Mail-Back –Type Of Treatment: Incineration Hazardous Waste Treatment
Financing –Who?: Consumers? Waste Water Agencies? Retailers? Insurance Companies? Local, State or Federal Government? Manufacturers? –How?: Surcharge On Prescriptions? Higher Utility Bills? Higher Insurance Rates? Higher Taxes? –How Much?: Per Pound? Per Script? Per Mailer?
Implications –Reduces Teen Pharming –Increases Patient Safety –Environmental Impact –Child and Elder Safety
Partnerships –Waste Water Agencies –City and State Government –County Health –Public/Private Organizations –BAPPG (Bay Area Pollution Prevention Group) –Save The Bay (NGO) –Pharmacies –EPA –USPS –DEA –DHS –DTSC
Questions? Mark Harvey Director of Operations 48021 Warm Springs Blvd Fremont, CA 94539 Phone: 510-933-0936 Email: MarkRH@expworld.comMarkRH@expworld.com